Sharps Compliance Corp. (SMED) News
Filter SMED News Items
SMED News Results
|Loading, please wait...|
SMED News Highlights
- For SMED, its 30 day story count is now at 11.
- Over the past 28 days, the trend for SMED's stories per day has been choppy and unclear. It has oscillated between 1 and 6.
- The most mentioned tickers in articles about SMED are PLUG and STAR.
Latest SMED News From Around the Web
Below are the latest news stories about Sharps Compliance Corp that investors may wish to consider to help them evaluate SMED as an investment opportunity.
While shareholders of Sharps Compliance (NASDAQ:SMED) are in the black over 3 years, those who bought a week ago aren't so fortunate
It hasn't been the best quarter for Sharps Compliance Corp. ( NASDAQ:SMED ) shareholders, since the share price has...
Plug Power's (PLUG) Q4 earnings are likely to have gained from the growing popularity of fuel-cell solutions. High costs and operating expenses, supply-chain issues and forex woes might have hurt.
Sharps Compliance (SMED) announced Monday the acquisition of a full-service route based waste solutions provider - Midwest Medical Waste - located in Kansas. It comes at the purchase
Sharps Compliance Acquires Midwest Medical Waste Expanding its Route Based Services and Footprint in Kansas
HOUSTON, Feb. 07, 2022 (GLOBE NEWSWIRE) -- Sharps Compliance Corp. (NASDAQ: SMED) (“Sharps” or the “Company”), a leading full-service national provider of comprehensive waste management solutions including medical, pharmaceutical and hazardous, today announced the acquisition of Midwest Medical Waste, Inc., a full-service, route-based provider of medical and hazardous waste solutions serving over 600 customer locations across Kansas. The purchase price was $4.35 million and consisted of 75% in c
In a report released today, Kevin Steinke from Barrington maintained a Buy rating on Sharps Compliance (SMED – Research Report), with a price target of $11.00. The company's shares closed last Thursday at $6.40, close to its 52-week low of $6.27. According to TipRanks.com, Steinke is a 4-star analyst with an average return of 11.2% and a 47.5% success rate. Steinke covers the Services sector, focusing on stocks such as Cross Country Healthcare, Cra International, and Icf International. Currently, the analyst consensus on Sharps Compliance is a Moderate Buy with an average price target of $11.00.
Second quarter revenue of $18.9 million increased 11% from the prior year and 36% sequentially Route-based customer locations increased 17% to 17,400 from 14,900 in the prior year Professional market billings grew 15% compared to prior year second quarter Unused medication revenue increased 9% driven by increased Inner Liner sales Immunization-related mailback billings increased by $2.8 million sequentially as compared to 1Q22, from $1.8 million to $4.6 million, reflecting COVID-19 vaccines and booster shots administered in the Retail Pharmacy market Closed on Affordable Medical Waste acquisition on October 22, 2021 Partnership with PharMerica recently announced to address the cost-effective and compliant management of unused medications in the long-term care market Cash balance of $36....
Sharps Compliance press release (SMED): Q2 GAAP EPS of $0.07 in-line.Revenue of $18.78M (+10.5% Y/Y) beats by $0.79M.
Sharps Compliance (SMED) delivered earnings and revenue surprises of -12.50% and 2.52%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Sharps Compliance (SMED) partners with PharMerica Corporation to make the Sharps MedSafe available to the long-term care, LTC, facilities in PharMerica''s network
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...